Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
Open Access
- 4 July 2018
- journal article
- research article
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 68 (3) , 251-273
Abstract
Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives ( 4a-c and 5a-c ) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The ( EZ )-7-cyano-6-((4-hydroxybenzylidene)amino)- N -( p -tolyl)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 4b ) and ( EZ )-6-((4-chlorobenzylidene)-amino)-7-cyano- N -( p -tolyl)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 5b ) bearing the electron donating methyl group showed the highest anti-inflammatory activity while ( EZ )-6-((4-chlorobenzylidene)amino)-7-cyano- N -phenyl-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 5a ) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds 4b and 5b displayed high anticancer activity with IC 50 in the range of 0.30–0.92 μmol L −1 against the three cell lines, while compound ( EZ )- N -(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 4c ) was the most active against MCF-7 cells ( IC 50 = 0.08 μmol L −1 ). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound 5b , the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.Keywords
This publication has 28 references indexed in Scilit:
- Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of actionBioorganic & Medicinal Chemistry, 2017
- An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agentsEuropean Journal of Medicinal Chemistry, 2016
- Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agentsEuropean Journal of Medicinal Chemistry, 2016
- Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic LiabilityMolecules, 2016
- The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human MalignanciesInternational Journal of Cell Biology, 2010
- Anti-Inflammatory Agents for Cancer TherapyMolecular and Cellular Pharmacology, 2009
- Non steroidal anti‐inflammatory drugs and COX‐2 inhibitors as anti‐cancer therapeutics: hypes, hopes and realityAnnals of Medicine, 2003
- Celecoxib: A Specific COX-2 Inhibitor with Anticancer PropertiesCancer Control, 2002
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI: Journal of the National Cancer Institute, 2002
- The role of cyclooxygenases in inflammation, cancer, and developmentOncogene, 1999